test

Kaiser Permanente Washington Health Research Institute hosts regular seminars where our scientists and collaborators present their research findings.

All are welcome.

 
Left: Aruna Kamineni, PhD, MPH, with Ali Thomas, MD, of Washington Permanente Medical Group

Upcoming seminars and events


June 27, 2022

Health Equity and Qualitative Research: Elijah Anderson

12:00-12:55 PM

The views expressed in the seminars and events hosted by KPWHRI do not necessarily reflect those of Kaiser Permanente

The Qualitative Research Program is very excited to announce that Professor Elijah Anderson will be kicking off our speaker series on health equity and qualitative research!

The Sterling Professor of Sociology and of African American Studies at Yale University, and one of the leading sociologists and urban ethnographers in the United States, Dr. Anderson is the author of a great number of books, including Black in White Space: The Enduring Impact of Color in Everyday Life (2022), Code of the Street: Decency, Violence, and the Moral Life of the Inner City (1999), and Streetwise: Race, Class, and Change in an Urban Community (1990), as well as dozens of articles and book chapters. The significance of his scholarship on race, inequality, criminal justice, and urban America has been recognized through numerous prestigious awards, including the 2017 Merit Award from the Eastern Sociological Society, the 2018 W.E.B. DuBois Career of Distinguished Scholarship Award, the 2021 Robert and Helen Lynd Award for Lifetime Achievement, and the 2021 Stockholm Prize in Criminology.

Join on your computer or mobile app
Click here to join the meeting
Or call in (audio only)
+1 213-533-9530,,863203261# United States, Los Angeles
Phone Conference ID: 863 203 261#


July 19, 2022

InvesT1D: Improving adolescent diabetes health at what cost?

4:00-4:55pm

The views expressed in the seminars and events hosted by KPWHRI do not necessarily reflect those of Kaiser Permanente

Davene R. Wright, PhD is a health care researcher who uses decision sciences methodologies to design patient-centered interventions and to promote policies that can improve the management of pediatric chronic diseases. Dr. Wright is based in the Department of Population Medicine, a research and academic partnership between the Harvard Pilgrim Health Care Institute and Harvard Medical School. There, she is part of the Center for Healthcare Research in Pediatrics and the Division of Chronic Disease Across the Lifecourse and she is on faculty in the Harvard PhD Program in Health Policy. Until 2019, Dr. Wright was an Assistant Professor in the University of Washington Departments of Pediatrics and Pharmacy. Dr. Wright received a BS in Polymer and Textile Chemistry from the Georgia Institute of Technology where she was a President’s Scholar and ORISE Fellow. She earned her PhD in Health Policy and Decision Sciences from Harvard University in 2012 where she was a recipient of the National Science Foundation Graduate Research Fellowship. She is a Trustee for the Society for Medical Decision Making (SMDM), co-chair of the SMDM 2022 North American annual meeting in Seattle, and co-chair of the Decision Sciences for Child Health Collaborative.  In her work, she utilizes conjoint analysis, economic evaluation, simulation modeling, health services research, and behavioral economic research methods. Dr. Wright’s work has been funded by NIH, the American Heart Association, and the American Diabetes Association. You can find her on Twitter @WrightCensored

Summary

By providing individuals with immediate, consistent inducements for tasks which do not provide proximal tangible benefits, financial incentives can improve short-term adherence to health behaviors. However, most financial incentive studies are not flexible, patient-centered, sustainable, and incentive payments lack an empirical basis. Using qualitative interviews with families, an ethical analysis, and a discrete choice experiment, we developed the InvesT1D intervention, which aims to improve adolescent adherence to type 1 diabetes management goals. In this talk, we will present our developmental research approach, results from our pilot randomized controlled trial, and we will discuss potential challenges to implementing such an intervention in the real-world.

Join on your computer or mobile app
Click here to join the meeting
Join with a video conferencing device
teams@evc.kp.org
Video Conference ID: 113 017 084 6
Alternate VTC dialing instructions
Or call in (audio only)
+1 213-533-9530,,724190246#  United States, Los Angeles
Phone Conference ID: 724 190 246#


past events

June 21, 2022

Estimated National Prescription Drug Savings from Applying Value-Based Prices

4:00-4:30pm

The views expressed in the seminars and events hosted by KPWHRI do not necessarily reflect those of Kaiser Permanente

Kai Yeung, PharmD, PhD, is a pharmacist and pharmaceutical economist with expertise in patient medication-use behaviors, insurance design, and outcomes research. His objective is to develop and evaluate incentives to encourage high-value use of health care services. Dr. Yeung has conducted research evaluating policies focused on specialty drug access, value-based insurance design, the consequences of insurance switching, and financial incentives. He combines applied econometric and cost-effectiveness analysis tools with a clinical understanding of prescription drugs and health insurance design to gain new insights in these areas.

Summary

This presentation will address the question, “How would national drug spending change from applying value-based pricing?”


June 7, 2022

Guidelines for Artificial Intelligence in Medicine: A review and content analysis

12:00-12:55pm
View the video presentation

The views expressed in the seminars and events hosted by KPWHRI do not necessarily reflect those of Kaiser Permanente

Norah Crossnohere, PhD, is a Research Scientist at The Ohio State University College of Medicine, Department of Biomedical Informatics. She is a social scientist whose research applies and advances mixed-methods approaches to measure patient experiences and preferences. She has experience in the use of choice experiments, patient engagement methods, and patient-reported outcome measures to inform medical decision-making across the translational spectrum. She has applied these methods in cancer, pediatric conditions, and rare diseases, as well as to inform patient-centered use of health information technologies.

Summary

Artificial intelligence (AI) is rapidly expanding in medicine even while lacking formal oversight or guidance. We sought to explore the content of published frameworks describing best practices for the use of AI in medicine. We identified thirteen frameworks reporting on general guidelines or reporting practices for the use of AI in medicine. Content analysis of the frameworks revealed five overarching considerations related to the oversight of AI in medicine, including: transparency, reproducibility, ethics, effectiveness, and engagement. Frameworks provided broad guidance for the oversight of AI in medicine, but notably offered less input on the role engagement approaches for oversight, and regarding the translational stage of surveillance. Identifying and optimizing strategies for engagement is essential to ensure that AI can meaningfully benefit patients and other end-users.


February 1, 2022

Value-Based Payment: Impact on Outcomes and Equity

12:00-12:55pm
View the video presentation

The views expressed in the seminars and events hosted by KPWHRI do not necessarily reflect those of Kaiser Permanente

Speaker: Joshua M. Liao, MD, MSc, FACP (He/Him), is a board-certified internal medicine physician and faculty in the UW Schools of Medicine and Public Health, where he is also the Associate Chair for Health Systems in the Department of Medicine and the Medical Director of Payment Strategy at UW Medicine. He is also an Adjunct Senior Fellow at the Leonard Davis Institute of Health Economics at the University of Pennsylvania.

Dr. Liao's scholarship focuses on how systems of financing and delivering care work together with human behavior to affect health outcomes. Equity in payment and care delivery redesign is a key focus of this portfolio, which spans multiple federally funded grants, policymaker collaborations, and advocacy work. His payment expertise includes service on the US Department of Health and Human Services' Physician-Focused Payment Model Technical Advisory Committee (PTAC), as well as an advisor to the American Medical Association's RVU Update Committee (RUC).

Summary

Review of Dr. Liao’s research evaluating the association between payment models. Such as bundled payments and ACOs on patient outcomes and health disparities. Articulate areas of needed future work in payment and policy research.


January 18, 2022

Adolescent Depression and Suicidality: Rethinking Intervention

4:00-4:55pm
View the video presentation

The views expressed in the seminars and events hosted by KPWHRI do not necessarily reflect those of Kaiser Permanente

Speaker: Elizabeth McCauley, PhD, ABPP, (she/her). Clinically I serve as an Attending on the Psychiatry/Psychology CL service at SCH and a provider in the Crisis Care Clinic (CCC). The CCC is a new program we have developed specifically to address needs of suicidal youth and their families.  We are currently beginning a NIMH trial to study the efficacy of our CCC model of care as well as the Suicide Prevention Intervention- developed by Barbara Stanley and Greg Brown. My motivation to do this work in informed by a concern that in the face of suicidality our mental health system has been overly reliant on ED evaluations and inpatient hospitalizations that increase focus on medicalization of what for many youths are more transient issues related to poor emotion regulation skills in the face of environmental stressors.

Summary
  • Summarize current findings on the efficacy of psychotherapeutic interventions in addressing suicidality among youth.
  • Discuss strategies to improve treatment approaches and outcomes that are more equitable by moving away from over medicalizing mental health crises and expanding access to care.